AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...
The groundbreaking decision is a win for harm reduction, though it also highlights absurd contradictions in the FDA's overall ...
Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company, Wednesday said that the U.S. Food and Drug ...
The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...
Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...
The Association of Com­munity Pharmacists of Nigeria (ACPN) has petitioned Benue State Governor Rev. Father Hyacinth Iormen Alia, urging an investi­gation into the State Ministry of Trade and ...
Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...
If you’re reading this, you probably know the value of the Mercury’s news reporting, arts and culture coverage, event ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...